Why It's Time to Buy This 1 Dividend Aristocrat
Even after recording its second straight week of gains, the S&P 500 index is still down 6% year to date. Accelerating inflation and looming interest rate hikes from the Federal Reserve are among several reasons behind the market's poor start to this year. But amid the market volatility, some stocks have fared well.
The pureplay medical devices maker Medtronic (NYSE: MDT) has enjoyed 2% in gains year to date. And despite this outperformance, I believe Medtronic can continue to better the market. Here are four reasons to explain why.
Medtronic reported earnings results for the third quarter in late February for the period ended Jan. 28. While the company missed analysts' revenue consensus for the quarter, it beat their predictions for non-GAAP (adjusted) diluted earnings per share (EPS).
Source Fool.com
